The proposed transaction is the result of an extensive strategic alternatives review process announced by the Company in February 2024 and is expected to result in minimal disruption to CENTOGENE's ...
Advancements in technologies such as next-generation sequencing, multi-omics approaches, and advanced imaging have significantly enhanced our understanding of the immune responses at the cellular and ...
Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk patients through the power of dynamic biopsy technology, announced it has ...
Jeon explained the project aims to use polyomic profiling – multiple layers of omics data such as RNA-seq, DNA methylation, and protein levels aggregated in the cancer database – and patient metadata, ...
In a recent publication in Nature Communications, researchers from the Tumor Profiler consortium combined single-cell multi-omics and functional profiling for 21 AML patients to reveal resistance ...